Common data model for decision support system of adverse drug reaction to extract knowledge from multi-center database

Mi Jung Rho, Si Ra Kim, Seung Ho Park, Kwang Soo Jang, Bum Joon Park, Joo Young Hong and In Young Choi ()
Additional contact information
Mi Jung Rho: The Catholic University of Korea
Si Ra Kim: The Catholic University of Korea
Kwang Soo Jang: The Hanyang University of Korea
Bum Joon Park: The Hanyang University of Korea
Joo Young Hong: The Catholic University of Korea
In Young Choi: The Catholic University of Korea

Information Technology and Management, 2016, vol. 17, issue 1, No 6, 57-66

Abstract: Abstract An adverse drug reaction (ADR) surveillance system integrated with various electronic medical record (EMR) systems has been suggested as an effective way to collect more data and analyze ADRs earlier than the spontaneous reporting of ADRs. Because Korean hospitals have heterogeneous EMR databases, a common data model (CDM) should first be defined to develop the multi-center EMR-based drug surveillance system. We investigated the data models from two prominent drug safety surveillance studies, the Mini-Sentinel program and the Observational Medical Outcomes Partnership, and developed an EMR-based ADR common data model (EADR CDM). The EADR CDM has eight tables, including a demographic table, drug table, visit table, procedure table, diagnosis table, death table, laboratory table and organization table. Each table consists of 5–12 fields. Among a total of 2,931,060 patients from January 2008 to December 2012 in clinical data warehouse of the S hospital, we extracted the data from 135,745 patients who were prescribed below drugs to determine whether the exported data were sufficient to detect ADRs of six drugs. After validation, we found that the transformed data based on EADR CDM is helpful to understand the prescription pattern and explore feasible medication list for adverse drug signal detection. The collection of diverse data using the CDM is an effective method of early decision of ADRs. This study provides guidelines for developing the CDM and plans to develop the drug safety surveillance system based on multi-center EMR.

Keywords: Adverse drug reactions; Common data model; EMR; Pharmacovigilance; Multi-center database (search for similar items in EconPapers)
Date: 2016
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
http://link.springer.com/10.1007/s10799-015-0240-6 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:infotm:v:17:y:2016:i:1:d:10.1007_s10799-015-0240-6

Ordering information: This journal article can be ordered from
http://www.springer.com/journal/10799

DOI: 10.1007/s10799-015-0240-6

Access Statistics for this article

Information Technology and Management is currently edited by Raymond Patterson and Erik Rolland

More articles in Information Technology and Management from Springer
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().